Evaluation of intron 22 and intron 1 inversions of the factor 8 gene using an inverse shifting PCR method in severe haemophilia A patients

被引:6
作者
Roozafzay, Narges [1 ,2 ]
Kokabee, Leila [2 ]
Zeinali, Sirous [2 ,3 ]
Karimipoor, Morteza [1 ,2 ]
机构
[1] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran
[2] Pasteur Inst Iran, Biotechnol Res Ctr, Dept Mol Med, Tehran, Iran
[3] Kawsar Genom & Biotech Ctr, Kawsar Human Genet Res Ctr, Tehran, Iran
来源
SCIENCEASIA | 2013年 / 39卷 / 02期
关键词
F8; DNA inversions; mutation; FACTOR-VIII GENE; COAGULATION-FACTOR-VIII; RECOMBINANT FACTOR-VIII; IDENTIFICATION; EXPRESSION; MUTATIONS; HOTSPOT;
D O I
10.2306/scienceasia1513-1874.2013.39.174
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Haemophilia A (HA) is an X-linked recessive bleeding disorder caused by several mutations in the F8 gene, whose inversion causes most of the mutation in 40% of severe HA patients. Methods such as long distance PCR and southern blot have been exploited to analyse intron 22 inversion in the F8 gene. For this purpose, we used an inverse shifting PCR assay, a novel genetic diagnostic method, for the detection of intron 22 inversion in severe HA patients. A screen for the presence of intron 22 and intron 1 inversions at the F8 gene in 30 Iranian severe HA patients revealed that 47% of patients showed intron 22 inversion (40% type 1 and 7% type 2), while 7% of patients had intron 1 inversion. Among the patients carrying the inversion, 12% developed inhibitors. Inverse shifting PCR is a precise method for assessment of rearrangements related to int 22h and int 1h in patients and carriers of haemophilia A. Since the previous methods of assessing inversion are time-consuming and demanding, this method can be a good replacement.
引用
收藏
页码:174 / 178
页数:5
相关论文
共 30 条
[1]   Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients [J].
Abou-Elew, Heba ;
Ahmed, Hanan ;
Raslan, Hanan ;
Abdelwahab, Magy ;
Hammoud, Rania ;
Mokhtar, Doha ;
Arnaout, Hanaa .
ANNALS OF HEMATOLOGY, 2011, 90 (05) :579-584
[2]   Int22h-related inversions causing hemophilia A:: a novel insight into their origin and a new more discriminant PCR test for their detection [J].
Bagnall, RD ;
Giannelli, F ;
Green, PM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (03) :591-598
[3]   Gene conversion and evolution of Xq28 duplicons involved in recurring inversions causing severe hemophilia A [J].
Bagnall, RD ;
Ayres, KL ;
Green, PM ;
Giannelli, F .
GENOME RESEARCH, 2005, 15 (02) :214-223
[4]   Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States [J].
Chorba, TL ;
Holman, RC ;
Clarke, MJ ;
Evatt, BL .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 66 (04) :229-240
[5]   Immune response against therapeutic factor VIII in hemophilia A patients - A survey of probable risk factors [J].
Dasgupta, Suryasarathi ;
Navarrete, Ana-Maria ;
Delignat, Sandrine ;
Wootla, Bharath ;
Andre, Sebastien ;
Nagaraja, Valakunja ;
Lacroix-Desmazes, Sebastien ;
Kaveri, Srinivas V. .
IMMUNOLOGY LETTERS, 2007, 110 (01) :23-28
[6]   Molecular characteristics of the intron 22 homologs of the coagulation factor VIII gene: an update [J].
De Brasi, C. D. ;
Bowen, D. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) :1822-1824
[7]   The protein structure and effect of factor VIII [J].
Fang, Hong ;
Wang, Lemin ;
Wang, Hongbao .
THROMBOSIS RESEARCH, 2007, 119 (01) :1-13
[8]   Laboratory, clinical and therapeutic aspects of acquired hemophilia A [J].
Franchini, Massimo ;
Targher, Giovanni ;
Montagnana, Martina ;
Lippi, Giuseppe .
CLINICA CHIMICA ACTA, 2008, 395 (1-2) :14-18
[9]   Mechanism of action, development and clinical experience of recombinant FVIIa [J].
Hedner, Ulla .
JOURNAL OF BIOTECHNOLOGY, 2006, 124 (04) :747-757
[10]   History of rFVIIa therapy [J].
Hedner, Ulla .
THROMBOSIS RESEARCH, 2010, 125 :S4-S6